Characteristics of patients with enteropathy-type intestinal T cell lymphoma (ETCL)
| Patient No | Sex/Age | Clinical signs of entheropathy | Histology | PET result | SUV |
|---|---|---|---|---|---|
| PET, positron emission tomograph; CD, coeliac disease; SUV, standard uptake value. | |||||
| *Onset of gluten free diet prior to (first) PET scan. | |||||
| 1 | F/60 | CD (20*) | ETCL | Focal intestinal FDG uptake | 7.7 |
| 2 | F/58 | Intestinal ulceration | ETCL | Focal intestinal FDG uptake | 6.4 |
| 3 | M/62 | No clinical signs | ETCL | Focal intestinal and intrapulmonary FDG uptake (confirmed by autopsy) | 6.5 |
| 4 | F/58 | CD (12*) | ETCL (after chemotherapy) | 4×follow up PET, 4×negative | Neg |
| 5 | F/44 | No clinical signs | ETCL | 1st PET: focal intestinal FDG uptake; 2nd PET (after chemotherapy): negative | 1st PET: 8.0 2nd PET: neg |